Obox3 inhibitors, as listed, are primarily focused on modulating epigenetic mechanisms and chromatin architecture, which are upstream processes influencing the transcriptional activity of genes like Obox3. The central theme among these inhibitors is their role in altering the chromatin state, either through histone modification or DNA methylation, thereby indirectly affecting the transcriptional regulation activities of Obox3. Histone deacetylase inhibitors like Trichostatin A, Vorinostat, Panobinostat, Entinostat, and Romidepsin function by preventing the removal of acetyl groups from histones. This process results in a more relaxed chromatin structure, leading to increased transcriptional activity of various genes, potentially including those regulated by Obox3. By modifying the chromatin landscape, these inhibitors can indirectly influence the transcriptional regulation exerted by Obox3.
On the other hand, DNA methyltransferase inhibitors, such as 5-Azacytidine and Decitabine, alter gene expression by affecting DNA methylation patterns. These agents reduce the methylation of DNA, a process often associated with gene silencing. By altering the methylation status, these inhibitors can impact the expression of genes under the regulatory scope of Obox3. Additionally, compounds like JQ1, GSK343, EPZ-6438 (Tazemetostat), CPI-1205, and UNC1999 target the BET bromodomain proteins and EZH2, respectively. These are involved in modifying chromatin structure and histone methylation patterns. By inhibiting these proteins, the compounds can indirectly influence the transcriptional activity regulated by Obox3, particularly in the context of developmental and cellular differentiation processes. In summary, while direct inhibitors of Obox3 are not currently identified, the chemicals listed here offer potential routes to indirectly modulate its activity. These inhibitors work by altering the epigenetic landscape, chromatin architecture, and histone modification states, all of which are crucial for the proper functioning of transcription factors like Obox3.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, potentially affecting chromatin structure and gene expression, indirectly influencing Obox3 transcriptional activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, altering DNA methylation and potentially affecting gene expression patterns including those regulated by Obox3. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
A BET bromodomain inhibitor, affecting chromatin remodeling and potentially influencing transcription factors like Obox3. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor, potentially affecting the chromatin state and indirectly influencing Obox3 activity. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to 5-Azacytidine, this compound is a DNA methyltransferase inhibitor that could indirectly affect Obox3 function. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A potent histone deacetylase inhibitor, potentially altering the transcriptional activity regulated by Obox3. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A selective histone deacetylase inhibitor, potentially affecting gene expression patterns linked to Obox3. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
A histone deacetylase inhibitor, possibly influencing the transcriptional activity of Obox3. | ||||||
GSK343 | 1346704-33-3 | sc-397025 sc-397025A | 5 mg 25 mg | $151.00 $461.00 | 1 | |
An EZH2 inhibitor, affecting histone methylation and potentially the gene expression regulated by Obox3. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
Another EZH2 inhibitor, potentially influencing chromatin state and Obox3-mediated transcription. | ||||||